Insider Transactions in Q1 2022 at Axogen, Inc. (AXGN)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 30
2022
|
Quentin S. Blackford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,036
+10.0%
|
-
|
|
Mar 16
2022
|
Isabelle Billet Chief Strategy and BD Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,447
-10.1%
|
$17,129
$7.97 P/Share
|
|
Mar 16
2022
|
Isabelle Billet Chief Strategy and BD Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+25.98%
|
-
|
|
Mar 16
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,497
-1.59%
|
$10,479
$7.97 P/Share
|
|
Mar 16
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+6.0%
|
-
|
|
Mar 16
2022
|
Michael Patrick Donovan VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,512
-2.38%
|
$10,584
$7.97 P/Share
|
|
Mar 16
2022
|
Michael Patrick Donovan VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+8.64%
|
-
|
|
Mar 16
2022
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,502
-5.81%
|
$10,514
$7.97 P/Share
|
|
Mar 16
2022
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+18.84%
|
-
|
|
Mar 16
2022
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,769
-7.41%
|
$19,383
$7.97 P/Share
|
|
Mar 16
2022
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+22.75%
|
-
|
|
Mar 16
2022
|
Bradley Ottinger General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
648
-17.41%
|
$4,536
$7.97 P/Share
|
|
Mar 16
2022
|
Bradley Ottinger General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
2,563
+40.79%
|
-
|
|
Mar 16
2022
|
Eric Sandberg Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,512
-10.57%
|
$10,584
$7.97 P/Share
|
|
Mar 16
2022
|
Eric Sandberg Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+29.54%
|
-
|
|
Mar 16
2022
|
Angelo Scopelianos Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,770
-12.07%
|
$19,390
$7.97 P/Share
|
|
Mar 16
2022
|
Angelo Scopelianos Chief R&D Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+32.4%
|
-
|
|
Mar 16
2022
|
Karen L. Zaderej CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,950
+2.62%
|
-
|
|
Mar 16
2022
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,239
-16.59%
|
$22,673
$7.97 P/Share
|
|
Mar 16
2022
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,866
+29.35%
|
-
|
|
Feb 22
2022
|
Michael Patrick Donovan VP Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+12.01%
|
$75,000
$5.27 P/Share
|
|
Feb 15
2022
|
Isabelle Billet Chief Strategy and BD Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
447
-2.77%
|
$3,576
$8.42 P/Share
|
|
Feb 15
2022
|
Isabelle Billet Chief Strategy and BD Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+7.58%
|
-
|
|
Feb 15
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-0.4%
|
$2,856
$8.42 P/Share
|
|
Feb 15
2022
|
Erick Wayne De Vinney Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,181
+1.32%
|
-
|
|
Feb 15
2022
|
Michael Patrick Donovan VP Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
205
-0.48%
|
$1,640
$8.42 P/Share
|
|
Feb 15
2022
|
Michael Patrick Donovan VP Operations |
BUY
Grant, award, or other acquisition
|
Direct |
675
+1.56%
|
-
|
|
Feb 15
2022
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-1.77%
|
$2,856
$8.42 P/Share
|
|
Feb 15
2022
|
Mark Louis Friedman VP Regulatory Affairs & Policy |
BUY
Grant, award, or other acquisition
|
Direct |
1,181
+5.52%
|
-
|
|
Feb 15
2022
|
Peter J Mariani EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
950
-3.48%
|
$7,600
$8.42 P/Share
|
|
Feb 15
2022
|
Peter J Mariani EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,157
+10.36%
|
-
|
|
Feb 15
2022
|
Maria D. Martinez Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-5.67%
|
$3,200
$8.42 P/Share
|
|
Feb 15
2022
|
Maria D. Martinez Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+15.81%
|
-
|
|
Feb 15
2022
|
Angelo Scopelianos Chief R&D Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
400
-3.24%
|
$3,200
$8.42 P/Share
|
|
Feb 15
2022
|
Angelo Scopelianos Chief R&D Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,325
+9.69%
|
-
|
|
Feb 15
2022
|
Eric Sandberg Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
762
-8.4%
|
$6,096
$8.42 P/Share
|
|
Feb 15
2022
|
Eric Sandberg Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,531
+21.81%
|
-
|
|
Feb 15
2022
|
Karen L. Zaderej CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,978
+1.46%
|
-
|